Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
deals
gene therapy
life sciences
national blog main
national top stories
new york blog main
2
×
new york top stories
san diego blog main
san diego top stories
san francisco
2
×
san francisco blog main
san francisco top stories
startups
vc
2
×
acetylon pharmaceuticals
adeno-associated virus
alexandria venture investments
altitude life science ventures
ambys medicines
american society of gene and cell therapy
arch venture partners
boxer capital
cell therapy
constellation pharmaceuticals
dravet syndrome
ed kaye
encoded therapeutics
genentech
generation bio
hemophilia
holger willenbring
illumina
illumina ventures
ipo
jeffrey tong
juan carlos izpisua belmonte
keith dionne
What
aiming
ambys
big
biotech
control
crude
cutting
deadly
deal
debuted
despite
diseases
edge
effects
encoded
formed
future
gene
help
illumina’s
lasting
launch
limited
limits
liver
long
make
medicine
medicines
nabs
new
progress
promising
push
remains
single
startup
takeda
therapy
therapy’s
Language
Current search:
vc
×
" san francisco "
×
" new york blog main "
×
@xconomy.com
4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
